This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2008
Title: Innovations of Jian-Jun Liu
Introduction
Jian-Jun Liu is an accomplished inventor based in Parlin, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic methods for respiratory disorders. With a total of 2 patents, Liu's work showcases his dedication to advancing medical science.
Latest Patents
Liu's latest patents include the invention titled "Catalytic domain of ADAM33 and methods of use thereof." This invention discloses purified polypeptides that comprise an active ADAM33 catalytic domain. Additionally, it reveals nucleic acids that encode these polypeptides. The invention also outlines methods for growing X-ray diffractable crystals of polypeptides containing the active ADAM33 catalytic domain. Furthermore, it describes how these crystals can be utilized in structure-based drug design to identify compounds that modulate the enzymatic activity of ADAM33. Importantly, the invention presents methods for treating respiratory disorders by administering therapeutic amounts of the ADAM33 catalytic domain.
Career Highlights
Jian-Jun Liu is currently associated with Schering Corporation, where he continues to innovate and contribute to the field. His work has been instrumental in developing new therapeutic approaches that can potentially improve patient outcomes.
Collaborations
Liu has collaborated with notable colleagues, including Wenyan Wang and Hung V Le. These partnerships have further enhanced the impact of his research and inventions.
Conclusion
Jian-Jun Liu's contributions to the field of biochemistry, particularly through his patents related to the ADAM33 catalytic domain, highlight his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for improving treatments for respiratory disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
